Variant report

Variant	rs73382344
Chromosome Location	chr22:22012882-22012883
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr22:22010757-22013057	HepG2	liver:	n/a	n/a
2	POLR2A	chr22:22010788-22012887	K562	blood:	n/a	n/a
3	BACH1	chr22:22012764-22012964	H1-hESC	embryonic stem cell:	n/a	n/a
4	MAX	chr22:22011460-22013054	HepG2	liver:	n/a	n/a
5	POLR2A	chr22:22010937-22013070	ECC-1	luminal epithelium:	n/a	n/a
6	ELF1	chr22:22012646-22013065	K562	blood:	n/a	n/a
7	POLR2A	chr22:22010706-22013104	K562	blood:	n/a	n/a
8	GABPA	chr22:22010948-22013121	K562	blood:	n/a	chr22:22011787-22011801 chr22:22011842-22011851
9	TEAD4	chr22:22010067-22013120	K562	blood:	n/a	n/a
10	POLR2A	chr22:22011259-22012988	GM12878	blood:	n/a	n/a
11	E2F6	chr22:22011463-22013037	H1-hESC	embryonic stem cell:	n/a	chr22:22011842-22011851 chr22:22012323-22012335 chr22:22011968-22011977 chr22:22011879-22011888 chr22:22012195-22012209
12	POLR2A	chr22:22010868-22012940	K562	blood:	n/a	n/a
13	TEAD4	chr22:22010722-22013097	K562	blood:	n/a	n/a
14	TBP	chr22:22012084-22012958	H1-hESC	embryonic stem cell:	n/a	n/a
15	SPI1	chr22:22012810-22012968	K562	blood:	n/a	n/a
16	POLR2A	chr22:22010892-22012963	GM19099	blood:	n/a	n/a
17	POLR2A	chr22:22010732-22012984	K562	blood:	n/a	n/a
18	MAX	chr22:22011576-22012891	ECC-1	luminal epithelium:	n/a	n/a
19	ZNF143	chr22:22011313-22012954	H1-hESC	embryonic stem cell:	n/a	chr22:22012390-22012408
20	POLR2A	chr22:22010774-22013018	K562	blood:	n/a	n/a
21	POLR2A	chr22:22010926-22013030	H1-hESC	embryonic stem cell:	n/a	n/a
22	SIN3A	chr22:22011253-22012991	H1-hESC	embryonic stem cell:	n/a	chr22:22011752-22011763 chr22:22012319-22012330
23	HDAC2	chr22:22010758-22012993	K562	blood:	n/a	n/a
24	MAX	chr22:22010771-22012997	K562	blood:	n/a	n/a
25	NR2F2	chr22:22010414-22013006	K562	blood:	n/a	n/a
26	MAX	chr22:22011387-22013058	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr22:22010786-22013047	SK-N-SH	brain:	n/a	n/a
28	YY1	chr22:22011270-22012927	K562	blood:	n/a	chr22:22012300-22012311 chr22:22011840-22011854 chr22:22012302-22012311 chr22:22011917-22011926 chr22:22011879-22011888 chr22:22011842-22011851 chr22:22011752-22011763
29	HEY1	chr22:22012368-22013042	K562	blood:	n/a	n/a
30	SP2	chr22:22012425-22013014	K562	blood:	n/a	n/a
31	NR2F2	chr22:22010426-22013072	K562	blood:	n/a	n/a
32	E2F6	chr22:22011591-22012894	H1-hESC	embryonic stem cell:	n/a	chr22:22011842-22011851 chr22:22012323-22012335 chr22:22011968-22011977 chr22:22011879-22011888 chr22:22012195-22012209
33	POLR2A	chr22:22010769-22013225	H1-hESC	embryonic stem cell:	n/a	n/a
34	ATF3	chr22:22012433-22013117	K562	blood:	n/a	n/a
35	POLR2A	chr22:22012875-22012915	HUVEC	blood vessel:	n/a	n/a
36	THAP1	chr22:22010948-22013022	K562	blood:	n/a	n/a
37	PBX3	chr22:22011522-22012886	SK-N-SH	brain:	n/a	n/a
38	MAX	chr22:22011236-22012981	HepG2	liver:	n/a	n/a
39	PML	chr22:22010631-22013148	K562	blood:	n/a	n/a
40	MAX	chr22:22011469-22012939	ECC-1	luminal epithelium:	n/a	n/a
41	POLR2A	chr22:22011016-22013016	U87	brain:	n/a	n/a
42	POLR2A	chr22:22005031-22015259	PFSK-1	brain:	n/a	n/a
43	PBX3	chr22:22011443-22013123	SK-N-SH	brain:	n/a	n/a
44	POLR2A	chr22:22010962-22012895	GM12878	blood:	n/a	n/a
45	POLR2A	chr22:22012374-22012933	H1-hESC	embryonic stem cell:	n/a	n/a
46	MAX	chr22:22011551-22012913	MCF-7	breast:	n/a	n/a
47	ZBTB7A	chr22:22010977-22012931	K562	blood:	n/a	n/a
48	POLR2A	chr22:22012716-22013040	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr22:22010239-22013078	K562	blood:	n/a	n/a
50	POLR2A	chr22:22010790-22013036	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr22:22011842..22015116-chr22:22321184..22324268,3	K562	blood:
2	chr22:22011088..22014764-chr22:22088779..22092551,4	K562	blood:
3	chr22:22011595..22013353-chr22:22082814..22084331,2	K562	blood:
4	chr22:21982609..21984758-chr22:22010076..22013251,4	MCF-7	breast:
5	chr22:22011149..22013585-chr22:22335702..22337428,2	K562	blood:
6	chr22:22009565..22013226-chr22:22291661..22294169,4	K562	blood:

Variant related genes	Relation type
ENSG00000272954	TF binding region
ENSG00000100034	Chromatin interaction
ENSG00000161179	Chromatin interaction
ENSG00000224086	Chromatin interaction
ENSG00000100038	Chromatin interaction
ENSG00000100027	Chromatin interaction

Extended variants
information (count: 19 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs73382331	0.84[AFR][1000 genomes]
rs73382335	1.00[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:17 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv914458	chr22:21747678-22070489	Enhancers Flanking Active TSS Active TSS Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	387 gene(s)	inside rSNPs	diseases
2	nsv482690	chr22:21807513-22016791	Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	374 gene(s)	inside rSNPs	diseases
3	esv1823866	chr22:21928916-22131125	Active TSS ZNF genes & repeats Strong transcription Flanking Active TSS Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	374 gene(s)	inside rSNPs	diseases
4	nsv948603	chr22:21928916-22601814	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	422 gene(s)	inside rSNPs	diseases
5	nsv948902	chr22:21928916-22657900	Weak transcription Enhancers Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	426 gene(s)	inside rSNPs	diseases
6	nsv1063962	chr22:21939722-22934593	Weak transcription Flanking Active TSS Enhancers Genic enhancers Strong transcription Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	477 gene(s)	inside rSNPs	diseases
7	nsv1058617	chr22:21939922-22934454	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	477 gene(s)	inside rSNPs	diseases
8	nsv529694	chr22:21957411-22905068	Enhancers Genic enhancers Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	474 gene(s)	inside rSNPs	diseases
9	nsv914464	chr22:21964761-22039863	Genic enhancers Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	367 gene(s)	inside rSNPs	diseases
10	nsv914465	chr22:21964761-22055280	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	368 gene(s)	inside rSNPs	diseases
11	nsv914466	chr22:21964761-22057273	Strong transcription Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	368 gene(s)	inside rSNPs	diseases
12	nsv531797	chr22:21977700-22959729	Enhancers Weak transcription Active TSS Genic enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	476 gene(s)	inside rSNPs	diseases
13	nsv914467	chr22:21982892-22055280	Strong transcription Genic enhancers Weak transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	363 gene(s)	inside rSNPs	diseases
14	nsv914468	chr22:21982892-22070489	Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	365 gene(s)	inside rSNPs	diseases
15	esv3456722	chr22:21993383-22019246	Enhancers Active TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	341 gene(s)	inside rSNPs	diseases
16	esv3456723	chr22:21993399-22019258	Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	341 gene(s)	inside rSNPs	diseases
17	nsv1066403	chr22:22010822-22352262	Genic enhancers Enhancers Weak transcription Active TSS Strong transcription Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	51 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:22007600-22019800	Weak transcription	Fetal Heart	heart
2	chr22:22011200-22013000	Active TSS	ES-I3 Cell Line	embryonic stem cell
3	chr22:22011200-22013000	Enhancers	Fetal Brain Male	brain
4	chr22:22011400-22013000	Active TSS	H9 Cell Line	embryonic stem cell
5	chr22:22011600-22013200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr22:22011800-22013000	Active TSS	Esophagus	oesophagus
7	chr22:22011800-22013000	Active TSS	GM12878-XiMat	blood
8	chr22:22012000-22013000	Flanking Active TSS	K562	blood
9	chr22:22012400-22013000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr22:22012400-22013000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
11	chr22:22012400-22013000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr22:22012400-22013000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
13	chr22:22012400-22013000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
14	chr22:22012400-22013000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
15	chr22:22012400-22013000	Enhancers	Primary T killer memory cells from peripheral blood	blood
16	chr22:22012400-22013000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr22:22012400-22013000	Flanking Active TSS	HepG2	liver
18	chr22:22012400-22013200	Flanking Active TSS	Dnd41	blood
19	chr22:22012600-22013000	Flanking Active TSS	H1 Cell Line	embryonic stem cell
20	chr22:22012600-22013000	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr22:22012600-22013000	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr22:22012600-22013000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
23	chr22:22012600-22013000	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr22:22012600-22013000	Enhancers	Primary B cells from cord blood	blood
25	chr22:22012600-22013000	Enhancers	Primary hematopoietic stem cells	blood
26	chr22:22012600-22013000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
27	chr22:22012600-22013000	Flanking Active TSS	Brain Germinal Matrix	brain
28	chr22:22012600-22013000	Flanking Active TSS	Fetal Brain Female	brain
29	chr22:22012600-22013000	Bivalent Enhancer	Fetal Intestine Small	intestine
30	chr22:22012600-22013000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr22:22012600-22013000	Bivalent Enhancer	Fetal Muscle Leg	muscle
32	chr22:22012600-22013000	Flanking Bivalent TSS/Enh	Placenta	Placenta
33	chr22:22012600-22013000	Enhancers	Fetal Thymus	thymus
34	chr22:22012600-22013000	Enhancers	Pancreas	Pancrea
35	chr22:22012600-22013000	Strong transcription	Right Atrium	heart
36	chr22:22012800-22013000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr22:22012800-22013000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr22:22012800-22013000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
39	chr22:22012800-22013000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
40	chr22:22012800-22013000	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
41	chr22:22012800-22013000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
42	chr22:22012800-22013000	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr22:22012800-22013000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr22:22012800-22013000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
45	chr22:22012800-22013000	Enhancers	Primary T cells fromperipheralblood	blood
46	chr22:22012800-22013000	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr22:22012800-22013000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
48	chr22:22012800-22013000	Active TSS	Primary T regulatory cells fromperipheralblood	blood
49	chr22:22012800-22013000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr22:22012800-22013000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links